Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00253214
Status:
COMPLETED
Last Update Posted:
2011-05-23
First Post:
2005-11-10
Brief Title:
Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimers Disease Safety and Efficacy of a Controlled-Release Formulation
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC